Literature DB >> 24811818

Antitumor effects of a polypeptide isolated from Tegillarca granosa linnaeus and the related molecular mechanism.

Wenhua Xu1, Zhishang Chang1, Xiaoyan Liu2, Changqing Jiang3, Chunbo Wang1, Luo Xu1.   

Abstract

This study is to investigate the anticancer effects and mechanisms of Tegillarca granosa Linnaeus-1 (TG-1) on renal carcinoma OS-RC-2 cells in vitro. The proliferation of OS-RC-2 cells was evaluated under various concentrations of TG-1 using MTT assay. The apoptosis of OS-RC-2 cells was analyzed using acridine orange/ethidium bromide staining. And the cell cycle distribution of OS-RC-2 cells was detected by flow cytometry. In addition, the expression level of Ki67 mRNA was examined by RT-PCR and level of casepase-3 was examined by Western blot analysis. TG-1 incubation significantly inhibited the proliferation of renal carcinoma OS-RC-2 cells and arrested cells at G0/G1 phase (P <0.05). And TG-1 also significantly inhibited the expression of Ki67 mRNA (P<0.05). Additionally, TG-1 significantly promoted apoptosis and the expression of caspase-3 in cells (P<0.05). Moreover, the optimal effects of TG-1 was achieved at the concentration of 100 mg/L The results indicate that TG-1 has antitumor effects on renal carcinoma OS-RC-2 cells and that the underlying mechanisms may be acted through inhibiting proliferation and Ki67 mRNA expression, and promoting apoptosis and caspase-3 expression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24811818

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  2 in total

1.  The impact of Tegillarca granosa extract haishengsu on HL-60 cell.

Authors:  Jinshen Wang; Lixia Wei; Yueqin Han; Daogang Qin; Qiaozhi Yang; Xiuli Ju
Journal:  Open Med (Wars)       Date:  2015-08-03

2.  The anti-tumor effect of a polypeptide extracted from Tegillarca granosa Linnaeus on renal metastatic tumor OS-RC-2 cells.

Authors:  Wenhua Xu; Xiaoying Kong; Changqing Jiang; Xiaoyan Liu; Luo Xu
Journal:  Arch Med Sci       Date:  2015-08-11       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.